Tempest Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.About TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients.
CEOStephen R. Brady
CEOStephen R. Brady
Employees25
Employees25
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees25
Employees25
TPST Key Statistics
Market cap16.75M
Market cap16.75M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume337.47K
Average volume337.47K
High today$3.48
High today$3.48
Low today$3.24
Low today$3.24
Open price$3.32
Open price$3.32
Volume246.54K
Volume246.54K
52 Week high$13.65
52 Week high$13.65
52 Week low$3.00
52 Week low$3.00
Stock Snapshot
With a market cap of 16.75M, Tempest Therapeutics(TPST) trades at $3.36. The stock has a price-to-earnings ratio of -0.34.
During the trading session on 2025-12-05, Tempest Therapeutics(TPST) shares reached a daily high of $3.48 and a low of $3.24. At a current price of $3.36, the stock is +3.7% higher than the low and still -3.4% under the high.
Trading activity shows a volume of 246.54K, compared to an average daily volume of 337.47K.
The stock's 52-week range extends from a low of $3.00 to a high of $13.65.
The stock's 52-week range extends from a low of $3.00 to a high of $13.65.
People also own
Based on the portfolios of people who own TPST. This list is generated using Robinhood data, and it’s not a recommendation.